Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Weeke

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Plos One|June 18, 2021
Insulin resistance genetic risk score and burden of coronary artery disease in patients referred for coronary angiographyRegitze Skals, Maria Lukács Krogager, Emil Vincent R Appel, et al.
International Journal of Cardiology|June 4, 2019
Polygenic predisposition to breast cancer and the risk of coronary artery diseaseMaria D'Souza, Morten Schou, Regitze Skals, et al.
Journal of the American Heart Association|March 21, 2023
Use of Nonrecommended Drugs in Patients With Brugada Syndrome: A Danish Nationwide Cohort StudyCamilla H B Jespersen, Johanna Krøll, Priya Bhardwaj, et al.
Plos One|December 20, 2018
Hypertension genetic risk score is associated with burden of coronary heart disease among patients referred for coronary angiographyMaria Lukács Krogager, Regitze Kuhr Skals, Emil Vincent R Appel, et al.
Plos One|October 26, 2023
Correction: Hypertension genetic risk score is associated with burden of coronary heart disease among patients referred for coronary angiographyMaria Lukács Krogager, Regitze Kuhr Skals, Emil Vincent R Appel, et al.
Lancet (London, England)|September 2, 2024
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trialsMikhail N Kosiborod, John Deanfield, Richard Pratley, et al.
Journal of the American College of Cardiology|September 1, 2024
The Effect of Semaglutide on Mortality and COVID-19-Related Deaths: An Analysis From the SELECT TrialBenjamin M Scirica, A Michael Lincoff, Ildiko Lingvay, et al.
Thrombosis and Haemostasis|December 16, 2014
A genome-wide association study of heparin-induced thrombocytopenia using an electronic medical recordJason H Karnes, Robert M Cronin, Jerome Rollin, et al.
Lancet (London, England)|August 24, 2024
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trialJohn Deanfield, Subodh Verma, Benjamin M Scirica, et al.
Communications Medicine|August 26, 2025
Subgrouping patients with ischemic heart disease by means of the Markov cluster algorithmAmalie D Haue, Peter C Holm, Karina Banasik, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Plos One|June 18, 2021
Insulin resistance genetic risk score and burden of coronary artery disease in patients referred for coronary angiographyRegitze Skals, Maria Lukács Krogager, Emil Vincent R Appel, et al.
International Journal of Cardiology|June 4, 2019
Polygenic predisposition to breast cancer and the risk of coronary artery diseaseMaria D'Souza, Morten Schou, Regitze Skals, et al.
Journal of the American Heart Association|March 21, 2023
Use of Nonrecommended Drugs in Patients With Brugada Syndrome: A Danish Nationwide Cohort StudyCamilla H B Jespersen, Johanna Krøll, Priya Bhardwaj, et al.
Plos One|December 20, 2018
Hypertension genetic risk score is associated with burden of coronary heart disease among patients referred for coronary angiographyMaria Lukács Krogager, Regitze Kuhr Skals, Emil Vincent R Appel, et al.
Plos One|October 26, 2023
Correction: Hypertension genetic risk score is associated with burden of coronary heart disease among patients referred for coronary angiographyMaria Lukács Krogager, Regitze Kuhr Skals, Emil Vincent R Appel, et al.
Lancet (London, England)|September 2, 2024
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trialsMikhail N Kosiborod, John Deanfield, Richard Pratley, et al.
Journal of the American College of Cardiology|September 1, 2024
The Effect of Semaglutide on Mortality and COVID-19-Related Deaths: An Analysis From the SELECT TrialBenjamin M Scirica, A Michael Lincoff, Ildiko Lingvay, et al.
Thrombosis and Haemostasis|December 16, 2014
A genome-wide association study of heparin-induced thrombocytopenia using an electronic medical recordJason H Karnes, Robert M Cronin, Jerome Rollin, et al.
Lancet (London, England)|August 24, 2024
Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trialJohn Deanfield, Subodh Verma, Benjamin M Scirica, et al.
Communications Medicine|August 26, 2025
Subgrouping patients with ischemic heart disease by means of the Markov cluster algorithmAmalie D Haue, Peter C Holm, Karina Banasik, et al.
Pageof 11